Tanya Heath

Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ.

AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA.

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles.

PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France.

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

EDF Renouvelables SA engages in alternative energy distribution and generation. It extracts though wind, solar, hydro, biomass, biofuel, and biogas sources. The company was founded in 1990 and is headquartered in Nanterre, France.

EDF Renouvelables Technologies SASU is a French clean technology company that offers turnkey clean energy solutions to commercial and industrial customers. The private company is based in Courbevoie, France, and the CEO of the company is Bruno Fyot. The company's solutions include solar, storage, smart EV charging, microgrids, and energy management systems. EDF Renouvelables Technologies specializes in building sustainable wind and solar power solutions and provides origination, development, and construction services for large-scale wind and solar power generation and storage projects. The company was founded in 2017 by a Caltech research group who developed a patented adaptive load management technology to optimize power consumption.

EGM Wind SAS owns and operates wind farms. It also engages in the development, construction and operation of power plants that use renewable energy sources. The company was founded in April 2008 and is headquartered in Courbevoie, France.

EDF EN Services Belgium NV provides maintenance services for onshore wind farms and solar power plants. The company is based in Brussels, Belgium. The Belgian company is ultimately controlled by the Government of France.

HydroStadium SA provides engineering services. It specializes in creation of whitewater and central routes. The company was founded in 2001 and is headquartered in Annecy, France.

Energie Du Haut Dourdou specializes in scientific and technical activities. The private company is based in Mudaison, France. The CEO of the French company is Nicolas Couderc.

EDF Nouveaux Business Holding SASU engages in investment activities, with interest in electric energy. The company is headquartered in Levallois-Perret, France.

Centrale Photovoltaïque de Distriport Fos is a private company based in Paris, France. The French company engages in electricity production.

EDF Energies Nouvelles Reparties SASU provides photovoltaic roofing and promotes renewable energy. It designs, markets, and installs solar panels. The company was founded on December 18, 2002 and is headquartered din Paris, France.

The European Wind Energy Association is a global organization that advocates for the use of wind power. The private company is based in Brussels, Belgium. With over 600 members in more than 50 countries, it is the largest and most influential wind energy network in the world. The Belgian company was founded by Lawrence D. Staudt. Giles Dickson has been the CEO of the company since 2015.

Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France.